Sugi Predict

Sugi Predict / Compounds / SCHEMBL1772889

SCHEMBL1772889

SCHEMBL1772889

Ic1ccc2ccccc2c1N(c1ccccc1)c1ccc(-c2ccc(N(c3ccccc3)c3c(I)ccc4ccccc34)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.35
▸ TDP1 Q9NUW8 3/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ CYP2A6 P11509 1/20 0.35
▸ CYP1A2 P05177 3/20 0.33
▸ CYP3A4 P08684 3/20 0.33
▸ CYP2D6 P10635 3/20 0.33
▸ CYP2C9 P11712 3/20 0.33
▸ CYP2C19 P33261 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ HPRT1 P00492 1/20 0.33
▸ HIF1A Q16665 2/20 0.31
▸ CYP1B1 Q16678 1/20 0.31
▸ LMNA P02545 1/20 0.30
▸ GLA P06280 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1775049 0.89 ESR1 (0.35) ALDH1A1TDP1HSD17B10TSHRCYP2A6
SCHEMBL5423923 0.82 SIGMAR1 (0.38) ALDH1A1TDP1HSD17B10TSHRCYP2A6
SCHEMBL9162154 0.80 CYP1A2 (0.44) ALDH1A1TDP1HSD17B10TSHRCYP2A6
SCHEMBL15910234 0.80 CYP1A2 (0.44) ALDH1A1TDP1HSD17B10TSHRCYP2A6
SCHEMBL75967 0.79 ALDH1A1 (0.38) ALDH1A1TDP1HSD17B10CYP1A2CYP3A4
SCHEMBL7065426 0.79 ALDH1A1 (0.38) ALDH1A1TDP1HSD17B10CYP1A2CYP3A4
SCHEMBL24154109 0.79 ALDH1A1 (0.36) ALDH1A1TDP1HSD17B10TSHRCYP2A6
SCHEMBL23430357 0.79 ALDH1A1 (0.36) ALDH1A1TDP1HSD17B10TSHRCYP2A6
SCHEMBL24154418 0.79 ALDH1A1 (0.36) ALDH1A1TDP1HSD17B10TSHRCYP2A6
SCHEMBL24154573 0.78 ALDH1A1 (0.38) ALDH1A1TDP1HSD17B10TSHRCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090058262-A1 Alkaline fluoride dope molecular films and applications for p-n junction and field-effect transistor LU ZHENG-HONG 2009-03-05 — — US claimed
US-20240206217-A1 Light-Emitting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-06-20 — — US disclosed
US-9705093-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-11 — — US disclosed
US-9221770-B2 Compounds having electron transport properties, their preparation and use MERCK PATENT GMBH (DE) 2015-12-29 — — US disclosed
EP-2318474-B1 COMPOUND HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES AND ITS PREPARATION AND USE MERCK PATENT GMBH (DE) 2015-05-27 — — EP disclosed
US-20140361268-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2014-12-11 — — US disclosed
EP-1996673-B1 ELECTROLUMINESCENT DEVICE INCLUDING GALLIUM COMPLEXES GLOBAL OLED TECHNOLOGY LLC (US) 2011-08-10 — — EP disclosed
US-20110108819-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2011-05-12 — — US disclosed
US-7863632-B2 High performance light-emitting devices NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2011-01-04 — — US disclosed
US-7750159-B2 electron injecting material 5,6-dihydro-dibenzo[b,j]-1,10-phenanthroline derivatives; broaden choices for an electrode material; low power consumption SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-07-06 — — US disclosed
US-20090058262-A1 Alkaline fluoride dope molecular films and applications for p-n junction and field-effect transistor LU ZHENG-HONG 2009-03-05 — — US disclosed
EP-2013314-A1 ELECTROLUMINESCENT DEVICE INCLUDING AN ANTHRACENE DERIVATIVE EASTMAN KODAK COMPANY (US) 2009-01-14 — — EP disclosed
WO-2007130263-A1 ELECTROLUMINESCENT DEVICE INCLUDING AN ANTHRACENE DERIVATIVE EASTMAN KODAK COMPANY (US) 2007-11-15 — — WO disclosed
US-20070246705-A1 High Performance Light-Emitting Devices NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2007-10-25 — — US disclosed
US-7271406-B2 Electron transport agents for organic electronic devices 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-09-18 — — US disclosed
US-20070145353-A1 Phenanthroline derivative and light emitting element and light emitting device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-06-28 — — US disclosed
WO-2007043354-A9 SPIROFLUORENE DERIVATIVE, MATERIAL FOR LIGHT-EMITTING ELEMENT, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2007-06-07 — — WO disclosed
US-20040214036-A1 Electron transport agents for organic electronic devices 3M INNOVATIVE PROPERTIES COMPANY 2004-10-28 — — US disclosed
US-6069442-A Organic electroluminescent device with inorganic electron transporting layer EASTMAN KODAK COMPANY (US) 2000-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110108819-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE SLC25A21, SLCO4C1, SLCO1B3 ALDH1A1 571/4885TDP1 3167/4885HSD17B10 992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.